Sun Pharma Advanced Research Co. Ltd. NSE:SPARC

Press Release Sep 22 2020

Published September 22, 2020 at 12:28 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated September 22, 2020, titled "SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics".

View Attachment